![An Bang Lu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
An Bang Lu
Director Ejecutivo en VISEN Pharmaceuticals .
Cargos activos de An Bang Lu
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VISEN Pharmaceuticals
![]() VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | 07/11/2018 | - |
Director Ejecutivo | 07/11/2018 | - | |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
![]() VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - |
Historial de carrera de An Bang Lu
Antiguos cargos conocidos de An Bang Lu.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
![]() VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Director/Miembro de la Junta | - | 01/06/2021 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Presidente | 01/01/2010 | 01/01/2014 |
Formación de An Bang Lu.
Taipei Medical University | Undergraduate Degree |
Estadísticas
Internacional
Islas Caimán | 2 |
Japón | 2 |
China | 2 |
Operativa
Director/Board Member | 3 |
Chief Executive Officer | 2 |
President | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
Empresas privadas | 2 |
---|---|
VISEN Pharmaceuticals
![]() VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Health Technology |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
![]() VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Health Technology |
- Bolsa de valores
- Insiders
- An Bang Lu
- Experiencia